CSIMarket


Eyepoint Pharmaceuticals Inc   (EYPT)
Other Ticker:  
 

Eyepoint Pharmaceuticals Inc

EYPT's Fundamental analysis








Looking into Eyepoint Pharmaceuticals Inc growth rates, revenue grew by 51.84 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 923

Laboratory Analytical Instruments industry recorded deterioration of revenues by -3.55 %

Eyepoint Pharmaceuticals Inc net loss deacreased by in III. Quarter 2023 year on year, Eyepoint Pharmaceuticals Inc net loss increased by -31.53 % in III. Quarter 2023 year on year,

More on EYPT's Growth


Eyepoint Pharmaceuticals Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 18.09 in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 24.53.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 4.58.


More on EYPT's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.55
 Tangible Book Value (Per Share $) 1.53

Eyepoint Pharmaceuticals Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 18.09 in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 24.53.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 4.58.

Eyepoint Pharmaceuticals Inc Price to Book Ratio is at 17.8 lower than Indusry Avg. of 272.19. and higher than S&P 500 Avg. of -2032.6

More on EYPT's Valuation

  Market Capitalization (Millions $) 1,043
  Shares Outstanding (Millions) 38
  Employees -
  Revenues (TTM) (Millions $) 43
  Net Income (TTM) (Millions $) -100
  Cash Flow (TTM) (Millions $) 58
  Capital Exp. (TTM) (Millions $) -3
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 4.55
  Tangible Book Value (Per Share $) 1.53

  Market Capitalization (Millions $) 1,043
  Shares Outstanding (Millions) 38
  Employees -
  Revenues (TTM) (Millions $) 43
  Net Income (TTM) (Millions $) -100
  Cash Flow (TTM) (Millions $) 58
  Capital Exp. (TTM) (Millions $) -3





  Ratio
   Capital Ratio (MRQ) 2.35
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 1.64
  Asset Turnover Ratio (TTM) 0.26
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com